Innovation NovaLign is developing a novel, minimally invasive method and apparatus for treating mid-shaft long bone fractures using an intermedullary stent and fixative agent.
Funding NovaLign has raised $13.8 million in its Series A and B financings.
Contact 2905 Premiere Pkwy, Suite 150
Duluth, GA 30097
888.935.4411 phone
